2018 ASTRO循证指南:非小细胞肺癌姑息胸部放疗(更新版)

2018-04-03 美国放射治疗及肿瘤学会 Pract Radiat Oncol. 2018 Apr 3.

2018年4月,美国放射治疗及肿瘤学会(ASTRO)更新发布了非小细胞肺癌姑息胸部放疗指南,该指南是对2011版指南的更新,指南针对姑息胸部外放射治疗新增3个关键问题:剂量和分级,支气管的效用近距离放射疗法,放化疗的并发症。

中文标题:

2018 ASTRO循证指南:非小细胞肺癌姑息胸部放疗(更新版)

英文标题:

Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline.

发布日期:

2018-04-03

简要介绍:

2018年4月,美国放射治疗及肿瘤学会(ASTRO)更新发布了非小细胞肺癌姑息胸部放疗指南,该指南是对2011版指南的更新,指南针对姑息胸部外放射治疗新增3个关键问题:剂量和分级,支气管的效用近距离放射疗法,放化疗的并发症。

 

拓展指南:非小细胞肺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ASTRO循证指南:非小细胞肺癌姑息胸部放疗(更新版))] GetToolGuiderByIdResponse(projectId=1, id=54b8c1c0015e8849, title=2018 ASTRO循证指南:非小细胞肺癌姑息胸部放疗(更新版), enTitle=Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline., guiderFrom=Pract Radiat Oncol. 2018 Apr 3., authorId=null, author=, summary=2018年4月,美国放射治疗及肿瘤学会(ASTRO)更新发布了非小细胞肺癌姑息胸部放疗指南,该指南是对2011版指南的更新,指南针对姑息胸部外放射治疗新增3个关键问题:剂量和分级,支气管的效用近距离放射疗法,放化疗的并发症。 , cover=, journalId=null, articlesId=null, associationId=9, associationName=美国放射治疗及肿瘤学会, associationIntro=美国放射治疗及肿瘤学会(ASTRO,American Society for Therapeutic Radiology Oncology)成立于1958年,其使命是:通过促进优质的患者监护推进放射肿瘤学的实践,为教育和专业发展提供机会,促进研究、传播研究结果并在快速发展的卫生保健环境中代表着放射肿瘤学。成立至今,ASTRO已拥有1万多名会员,包括放射肿瘤医师、放射肿瘤学护士、医用物理学家、放射治疗学家、剂量测定员和生物学家等等,是全球最大的放射肿瘤学组织之一。, copyright=0, guiderPublishedTime=Tue Apr 03 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年4月,美国放射治疗及肿瘤学会(ASTRO)更新发布了非小细胞肺癌姑息胸部放疗指南,该指南是对2011版指南的更新,指南针对姑息胸部外放射治疗新增3个关键问题:剂量和分级,支气管的效用近距离放射疗法,放化疗的并发症。 </P> <P> </P>拓展指南:<strong>与<font color=red>非小细胞肺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=d14321c0015e631d" title="2018 ESTRO指南:局部进展期非小细胞肺癌治疗中靶区定义" target=_blank>2018 ESTRO指南:局部进展期非小细胞肺癌治疗中靶区定义</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=61b921c0015593c2" title="NCCN临床实践指南:非小细胞肺癌(2018.V3)" target=_blank>NCCN临床实践指南:非小细胞肺癌(2018.V3)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4c45f1c00153a02f" title="NCCN临床实践指南:非小细胞肺癌(2018.V2)" target=_blank>NCCN临床实践指南:非小细胞肺癌(2018.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=53b9d1c001525291" title="NCCN临床实践指南:非小细胞肺癌(2018.V1)" target=_blank>NCCN临床实践指南:非小细胞肺癌(2018.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=19d8b1c00150618e" title="NCCN临床实践指南:非小细胞肺癌(2017.V9)" target=_blank>NCCN临床实践指南:非小细胞肺癌(2017.V9)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C" target=_blank>有关非小细胞肺癌更多指南</a></ul>, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌), TagDto(tagId=73212, tagName=姑息性胸部放疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6123, appHits=230, showAppHits=0, pcHits=4669, showPcHits=1825, likes=124, shares=10, comments=3, approvalStatus=1, publishedTime=Thu Apr 12 22:37:20 CST 2018, publishedTimeString=2018-04-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Apr 12 22:37:20 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 10:46:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ASTRO循证指南:非小细胞肺癌姑息胸部放疗(更新版))])
2018 ASTRO循证指南:非小细胞肺癌姑息胸部放疗(更新版)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=309757, encodeId=b626309e57b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJpBl6xwMmnsKibwxcAIltOH3nnCEQbNE6TDbYtCKe8hYI0oJrbduNqnJraM1PyyjPKU1suAzicYPaA/132, createdBy=eeaf2031798, createdName=海之蓝, createdTime=Fri Apr 27 09:49:25 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306049, encodeId=bf96306049e8, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Apr 15 15:35:13 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305871, encodeId=7f523058e184, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 15 04:59:12 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-27 海之蓝

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=309757, encodeId=b626309e57b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJpBl6xwMmnsKibwxcAIltOH3nnCEQbNE6TDbYtCKe8hYI0oJrbduNqnJraM1PyyjPKU1suAzicYPaA/132, createdBy=eeaf2031798, createdName=海之蓝, createdTime=Fri Apr 27 09:49:25 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306049, encodeId=bf96306049e8, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Apr 15 15:35:13 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305871, encodeId=7f523058e184, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 15 04:59:12 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-15 131****1460

    学习了受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=309757, encodeId=b626309e57b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJpBl6xwMmnsKibwxcAIltOH3nnCEQbNE6TDbYtCKe8hYI0oJrbduNqnJraM1PyyjPKU1suAzicYPaA/132, createdBy=eeaf2031798, createdName=海之蓝, createdTime=Fri Apr 27 09:49:25 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306049, encodeId=bf96306049e8, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Apr 15 15:35:13 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305871, encodeId=7f523058e184, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sun Apr 15 04:59:12 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-15 秀红

    学习了

    0